GLAUKOS CORP.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1998-01-01
- Employees
- 907
- Market Cap
- $7.4B
- Website
- http://www.glaukos.com
iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study
- Conditions
- Glaucoma, Open-Angle
- First Posted Date
- 2020-11-12
- Last Posted Date
- 2021-10-20
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 475
- Registration Number
- NCT04624685
- Locations
- 🇺🇸
Stiles Eyecare Excellence, Overland Park, Kansas, United States
🇺🇸Chicago Eye Specialists, Chicago, Illinois, United States
🇺🇸Kresge Eye Institute / Wayne State University, Detroit, Michigan, United States
Study of Exchange of Travoprost Intraocular Implant
- First Posted Date
- 2020-11-04
- Last Posted Date
- 2023-09-26
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 33
- Registration Number
- NCT04615403
- Locations
- 🇺🇸
The Eye Associates of Manatee, Manatee, Florida, United States
🇺🇸North Bath Eye Associates, Inc., Petaluma, California, United States
🇺🇸Center for Sight, Sarasota, Florida, United States
Clinical Study Comparing Two Models of a Travoprost Intraocular Implant
- Conditions
- Glaucoma, Open-AngleOcular Hypertension
- Interventions
- Combination Product: G2-TR intraocular implant containing travoprostDrug: Sham surgery + active-comparator eye drops
- First Posted Date
- 2019-03-08
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 560
- Registration Number
- NCT03868124
- Locations
- 🇺🇸
Center for Sight, Las Vegas, Nevada, United States
Investigation of the Glaukos® Trabecular Micro-Bypass System, Model iS3, in Subjects With Refractory Glaucoma
- Conditions
- Glaucoma
- Interventions
- Device: Model iS3 three-stent trabecular micro-bypass system
- First Posted Date
- 2018-08-21
- Last Posted Date
- 2021-04-23
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 65
- Registration Number
- NCT03639870
- Locations
- 🇺🇸
Glaucoma Associates of Tx, Dallas, Texas, United States
Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%
- Conditions
- Glaucoma, Open-AngleOcular Hypertension
- Interventions
- Combination Product: G2-TR intraocular implant containing travoprostDrug: Sham surgery + active-comparator eye drops
- First Posted Date
- 2018-05-09
- Last Posted Date
- 2024-11-29
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 590
- Registration Number
- NCT03519386
- Locations
- 🇺🇸
Vance Thompson Vision, Sioux Falls, South Dakota, United States
iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications
- Conditions
- Primary Open Angle Glaucoma (POAG)
- Interventions
- Device: iStent inject surgery
- First Posted Date
- 2018-03-27
- Last Posted Date
- 2022-09-09
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 6
- Registration Number
- NCT03478293
- Locations
- 🇧🇷
Department of Ophthalmology - UNIFESP/ Hospital São Paulo, São Paulo, Brazil
Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus
- Conditions
- Progressive Keratoconus
- Interventions
- Drug: Test Article ADrug: PlaceboDrug: Test Article BDevice: KXL medical device system
- First Posted Date
- 2018-02-22
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 201
- Registration Number
- NCT03442751
- Locations
- 🇺🇸
Ophthalmic Consultants of Boston, Waltham, Massachusetts, United States
Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery
- Conditions
- Corneal Ectasia
- Interventions
- Combination Product: Corneal Collagen Cross-linking
- First Posted Date
- 2017-10-24
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 200
- Registration Number
- NCT03319082
- Locations
- 🇺🇸
Carolina Cataract & Laser Center, Ladson, South Carolina, United States
🇺🇸Slade & Baker Vision, Houston, Texas, United States
🇺🇸Northwest Eye Surgeons, Seattle, Washington, United States
Open-Angle Glaucoma Subjects With Cataract Treated With Cataract Surgery Plus One iStent and One iStent Supra
- Conditions
- Glaucoma, Open-Angle
- Interventions
- Device: Cataract surgery plus one iStent and one iStent Supra implanted
- First Posted Date
- 2017-08-21
- Last Posted Date
- 2022-09-09
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 15
- Registration Number
- NCT03255785
- Locations
- 🇦🇲
Glaukos Investigator Sites, Yerevan, Armenia
A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra
- Conditions
- Glaucoma, Open-Angle
- Interventions
- Device: G2 and G3
- First Posted Date
- 2017-08-21
- Last Posted Date
- 2022-09-09
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 7
- Registration Number
- NCT03255798
- Locations
- 🇩🇪
Prof. Dr. med. Carl Erb, Berlin, Germany